Most Read This Week
- Consensus Treatment Guidelines for the Use of Methotrexate in Patients With Inflammatory Skin Diseases
- Efficacy and Safety of Treatment With Botulinum Toxin in Patients With Rosacea
- Vaccination Recommendations for Adults Receiving Biologics and Oral Therapies for Psoriasis and Psoriatic Arthritis
- Checkpoint Inhibitor–Induced Bullous Pemphigoid Differs From Spontaneous Bullous Pemphigoid
- Outcomes of Live Attenuated Vaccine Administration in Children With Atopic Dermatitis Treated With Dupilumab
Recently Updated
- Safety and Tolerability of Deucravacitinib in Patients With Moderate to Severe Plaque Psoriasis
- Anatomic Subtype–Based Differences in Patients With Extramammary Paget Disease
- AAD 2024: Narrow Band Ultraviolet B Add-On Phototherapy Enhances Effectiveness of Ritlecitinib
- AAD 2024: Bimekizumab Effective Through Four Years of Treatment in Plaque Psoriasis
- AAD 2024: Home Phototherapy More Effective Than Office Phototherapy for Psoriasis Treatment